| Literature DB >> 35874617 |
Paula P Navarro1,2.
Abstract
The three-dimensional organization of biomolecules important for the functioning of all living systems can be determined by cryo-electron tomography imaging under native biological contexts. Cryo-electron tomography is continually expanding and evolving, and the development of new methods that use the latest technology for sample thinning is enabling the visualization of ever larger and more complex biological systems, allowing imaging across scales. Quantitative cryo-electron tomography possesses the capability of visualizing the impact of molecular and environmental perturbations in subcellular structure and function to understand fundamental biological processes. This review provides an overview of current hardware and software developments that allow quantitative cryo-electron tomography studies and their limitations and how overcoming them may allow us to unleash the full power of cryo-electron tomography.Entities:
Keywords: cell biology; cryo-electron tomography; image processing; in situ structural biology; quantitative cryo-electron tomography
Year: 2022 PMID: 35874617 PMCID: PMC9296768 DOI: 10.3389/fmolb.2022.934465
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Cryo-electron tomography imaging across scales. Schematic representing resolution limitations for commonly used imaging methods in cellular and structural biology indicating resolution gaps and potential bridges. Cryo-electron tomography was initially restricted to image viruses, small bacteria cells, and thin regions of mammalian cells (e.g., axons and lamellipodia) at nanometer resolution. Software developments for pre-processing of tilt-series as beam-induced motion correction, tilt-series alignment refinement and 3D CTF-correction, and for STA as alignment refinement and classification, have allowed in situ structure determination in cryo-ET data by STA. On the other hand, technologies such as cryo-FIB milling and cryo-lift-out have allowed imaging of cells and multicellular organisms in situ, respectively. Relevant ongoing developments that help expand cryo-ET are pointed out by a black arrow at their corresponding length scale area. Montage ET allows image acquisition of larger field of views (FOV) without compromising resolution at the cost of elongated acquisition times (Peck et al., 2021; Yang et al., 2022). While microfluidic cryofixation of larger specimens during live-cell microscopy imaging is a promising tool to explore the opportunities for correlative light and electron microscopy studies (Fuest et al., 2019).
FIGURE 2Main considerations for quantitative cryo-ET. Each biological sample possesses an inherent thickness. Sample thickness conditions imaging strategies in cryo-ET (FOV, resolution and need of additional thinning methods, see Section 3). Common FOV and resolution for cryo-ET data acquisition are highlighted by a red box. The combination of these three factors (thickness, FOV and resolution) defines research strategies to answer specific biological questions whose resolution requirements depend on the visualization of size-dependent targets as biological processes (e.g., cell and organellar morphology) and interacting molecular partners (e.g., viral capsid and microtubular structure). Usually, projects aiming to characterize biological processes prioritize FOV over resolution to capture large features while projects that aim to determine the structure of a specific macromolecule by STA in situ structure determination prioritize resolution over FOV (number of particles). Segmentation strategies (based on denoised cryo-electron tomograms) are important to understand biological processes while STA is essential for structure determination in projects where interacting partners and molecular structure determination are envisioned. However, segmentation and STA are commonly needed on both types of projects, albeit with different resolution expectations (see Section 2). Example of bacterium adapted from Erickson and Anderson (2010) and tissue sample adapted from Siyavula; example of bacterium (Caulobacter crecentus) adapted from ed from Govers and Jacobs-Wagner (2020); example of viruses and phage adapted from from wikipedia by Anderson F. Brito; example of synapsis adapted from Tao et al. (2018); example of HIV capsid adapted from Schur et al. (2016).
Developments in Cryo-FIB milling.
| Step | Development | Improvements | Comments | Source |
|---|---|---|---|---|
| Cryo-FIB milling | AutoTEM, (Aquilos, Thermo Fisher Scientific) | Unsupervised milling | Thinning may need intervention when targeting specific regions (e g., bacterial division site). Manual polishing recommended |
|
| Lamellae thickness 50–150 nm | ||||
| 3–4 lamella per hour | ||||
| autolamella Aquilos, Thermo Fisher Scientific | Unsupervised milling | Improvements in tracking: needs a fiducial marker (e.g., cross-shaped marker created by ion beam) |
| |
| Lamellae thickness 210–250 nm | ||||
| 5 lamellae per hour | ||||
| SmartFIB (Zeiss Microscopy GmbH, Oberkochen, Germany) | Unsupervised milling | Improvements in tracking: backlash and drift correction |
| |
| Lamellae thickness: 117–379 nm. Average = 243 nm (Manual = 258 nm) | ||||
| 16.75 min per lamella (3–4 lamella per hour) | ||||
| Cryo-lift-out | Micromanipulation | Lamellae performance on multicellular organisms and tissues | 10 h per lamella |
|
| Success rate ∼ 20% | ||||
| Ongoing development | ||||
| SerialFIB Aquilos, Thermo Fisher Scientific | Unified operational software | Includes tools for cryo-FIB milling, CLEM imaging, volume imaging automation and cryo-lift-out |
| |
| Cryo-transfer | Glove box transferring | Reduced frost contamination | Improve vacuum conditions for milling |
|
| Cryo-shield and cryo-shutter | Reduced amorphous ice contamination rate | Increased session time | ||
| ∼90% of all intact lamellae were useable for cryo-ET imaging |